Open Your FREE Demat Account Now!

Viyash Scientific Ltd. Share Price

NSE
BSE

NSE : VIYASH

BSE : 512529

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹217.35

High

₹225.84

Price Summary

Previous Close ₹218.39
Day's Range ₹217.35 - ₹225.84
Open ₹224.59
52 Week Range ₹178.13 - ₹298.00
Volume 11,13,107
Market Cap ₹0.01
Previous Close ₹218.50
Day's Range ₹217.35 - ₹225.75
Open ₹224.05
52 Week Range ₹178.40 - ₹297.90
Volume 82,933
Market Cap ₹0.01

Stocks Summary

Trade Value ( ₹ in Lacs) 2,454.19
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.00
Price/Earning (TTM) 56.39
TTM EPS (₹) 3.87
P/E Ratio 45.14
Book Value(₹) 3.43
PAT Margin (%) 6.57
Face Value (₹) 2.00
ROCE(%) 13.10
Trade Value ( ₹ in Lacs) 183.90
Market Cap (₹ in Mn) 0.01
Dividend Yield(%) 0.00
Price/Earning (TTM) 56.39
TTM EPS (₹) 3.87
P/E Ratio 45.14
Book Value(₹) 3.43
PAT Margin (%) 6.57
Face Value (₹) 2.00
ROCE(%) 13.10

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 7916.4 13103.4
Expenses N/A N/A
PBT 483.4 491.7
Operating profit 0.0 0.0
Net profit 368.5 584.9

Shareholding Pattern

Promoters (% Holding)

49.24%

Mutual funds (% Holding)

7.13%

Non-Institution (% Holding)

39.86%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.60%

About Viyash Scientific Ltd.

Founded 1985
Managing Director Haribabu Bodepudi
NSE Symbol VIYASH

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,26,661.74 1,778.25 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,57,902.73 9,715.00 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,76,306.21 4,635.15 3,532.60 - 3,532.60
Laurus Labs Ltd. 1,29,242.68 2,392.00 917.95 - 917.95
Zydus Lifesciences Ltd. 1,24,089.48 1,244.00 835.50 - 835.50
Apollo Hospitals Enterprise Ltd. 1,20,779.11 8,400.00 6,696.50 - 6,696.50
Lenskart Solutions Ltd. 1,17,959.74 678.20 0.00 - 0.00
Dr. Reddy's Laboratories Ltd. 1,12,698.53 1,350.20 1,101.00 - 1,101.00
Cipla Ltd. 1,11,488.55 1,380.00 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,02,796.60 2,488.75 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Oct
17
2026
EQUITY Posted on Oct 17th 2026

Viyash Scientific informs about disclosure

Viyash Scientific has informed that it enclosed disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for White Oak Capital Management Consultants LLP.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
8
2026
EQUITY Posted on Oct 8th 2026

Viyash Scientific informs about allotment of equity shares

Viyash Scientific has informed that the Nomination and Remuneration Committee of the Company vide resolution passed by circulation on October 08, 2026, has approved the allotment of 1,35,880 equity shares of face value Rs. 2/- each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as detailed below: a. 79,000 equity shares at an exercise price of Rs. 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 56,880 equity shares at an exercise price of Rs.101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Consequent to the aforesaid allotment, the issued and paid-up equity share capital of the Company has increased from Rs. 88,32,55,340/- consisting of 44,16,27,670 Equity Shares of Rs. 2 each to Rs. 88,35,27,100, comprising of 44,17,63,550 Equity Shares of Rs. 2 each.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
18
2026
EQUITY Posted on Sep 18th 2026

Viyash Scientific informs about allotment under ESOP

Viyash Scientific has informed that he Nomination and Remuneration Committee of the Company vide resolution passed by circulation on September 18, 2026, has approved the allotment of 11,07,309 equity shares of face value Rs. 2/- each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as detailed below: a. 9,26,333 equity shares at an exercise price of Rs. 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 1,80,976 equity shares at an exercise price of Rs.101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. Consequent to the aforesaid allotment, the issued and paid-up equity share capital of the Company has increased from Rs. 88,10,40,722/- consisting of 44,05,20,361 Equity Shares of Rs. 2 each to Rs. 88,32,55,340/-, comprising of 44,16,27,670 Equity Shares of Rs. 2 each.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
4
2026
EQUITY Posted on Sep 4th 2026

Viyash Scientific informs about allotment of equity shares under ESOP

Viyash Scientific has informed that the Nomination and Remuneration Committee of the Company vide resolution passed by circulation on September 04, 2026, has approved the allotment of 6,12,773 equity shares of face value Rs 2 each, fully paid up, pursuant to the exercise of stock options under the Sequent Scientific Limited Employee Stock Option Plan 2020 (“Sequent ESOP 2020”) and the Viyash Scientific Limited Employee Stock Option Scheme 2026 (“Viyash ESOP 2026”), as follows: a. 2,30,001 equity shares at an exercise price of Rs 86 per equity share to eligible optionees under Sequent ESOP 2020. b. 3,82,772 equity shares at an exercise price of Rs 101 per equity share to eligible optionees under Viyash ESOP 2026. The aforesaid equity shares shall rank pari passu in all respects with the existing equity shares of the Company. 
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
31
2026
EQUITY Posted on Oct 31st 2026

Hindustan Biosciences informs about outcome of board meeting

Pursuant to Regulation 30 and other applicable Regulations of SEBI (LODR), 2015, Hindustan Biosciences has informed that the Board of Directors of the Company in its meeting held today, on October 31, 2026, approved the Un-Audited Standalone Financial Results of the company for the 2nd Quarter ended on 30th September 2026 along with the Limited Review Report; and resignation of Company secretary and Compliance Officer Took note of and accepted the resignation of Shailendra Vyas, Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company, tendered vide his resignation letter dated 31st October, 2026, with effect from the closing hours of 31st October, 2026, due to his decision to pursue an alternative career opportunity outside the Organisation. The details required under Regulation 30 of SEBI (LODR) Regulations, 2015 read with SEBI Master Circular dated November 11, 2024 are enclosed as Annexure A, and a copy of the resignation letter is enclosed as Annexure B. The meeting commenced at 01:00 PM and concluded at 02:00 PM. 

The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Viyash Scientific Ltd. ?

The current share price of Viyash Scientific Ltd. is ₹218.39 as of 2026-10-30.

The market capitalisation of Viyash Scientific Ltd. is ₹9,652.53 as of 2026-10-30.

The 1-year return of Viyash Scientific Ltd. is % as of .

The P/E ratio of Viyash Scientific Ltd. is 45.14 as of 2026-11-01.

The 52-week high and low of Viyash Scientific Ltd. are ₹298.00 and ₹178.13, respectively, as of 2026-10-30.

The dividend yield of Viyash Scientific Ltd. is 0.0% as of2026-10-30.

You can buy Viyash Scientific Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Viyash Scientific Ltd. is Haribabu Bodepudi.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore